These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36441814)
1. Identification of potent anti-Cryptosporidium new drug leads by screening traditional Chinese medicines. Kabir MHB; Recuenco FC; Mohd Zin NK; Watanabe N; Fukuda Y; Bando H; Watanabe K; Bochimoto H; Xuan X; Kato K PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010947. PubMed ID: 36441814 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice. Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052 [TBL] [Abstract][Full Text] [Related]
4. A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum. Choudhary HH; Nava MG; Gartlan BE; Rose S; Vinayak S mBio; 2020 Aug; 11(4):. PubMed ID: 32843543 [No Abstract] [Full Text] [Related]
5. A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box. Jumani RS; Bessoff K; Love MS; Miller P; Stebbins EE; Teixeira JE; Campbell MA; Meyers MJ; Zambriski JA; Nunez V; Woods AK; McNamara CW; Huston CD Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339392 [TBL] [Abstract][Full Text] [Related]
6. Novel acyl carbamates and acyl / diacyl ureas show in vitro efficacy against Toxoplasma gondii and Cryptosporidium parvum. Li K; Grooms GM; Khan SM; Hernandez AG; Witola WH; Stec J Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():80-90. PubMed ID: 33011650 [TBL] [Abstract][Full Text] [Related]
7. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis. Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186 [TBL] [Abstract][Full Text] [Related]
8. Novel lactate dehydrogenase inhibitors with in vivo efficacy against Cryptosporidium parvum. Li K; Nader SM; Zhang X; Ray BC; Kim CY; Das A; Witola WH PLoS Pathog; 2019 Jul; 15(7):e1007953. PubMed ID: 31356619 [TBL] [Abstract][Full Text] [Related]
9. A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis. Manjunatha UH; Vinayak S; Zambriski JA; Chao AT; Sy T; Noble CG; Bonamy GMC; Kondreddi RR; Zou B; Gedeck P; Brooks CF; Herbert GT; Sateriale A; Tandel J; Noh S; Lakshminarayana SB; Lim SH; Goodman LB; Bodenreider C; Feng G; Zhang L; Blasco F; Wagner J; Leong FJ; Striepen B; Diagana TT Nature; 2017 Jun; 546(7658):376-380. PubMed ID: 28562588 [TBL] [Abstract][Full Text] [Related]
15. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. Xiao L; Bern C; Limor J; Sulaiman I; Roberts J; Checkley W; Cabrera L; Gilman RH; Lal AA J Infect Dis; 2001 Feb; 183(3):492-7. PubMed ID: 11133382 [TBL] [Abstract][Full Text] [Related]
16. Distribution and clinical manifestations of Cryptosporidium species and subtypes in HIV/AIDS patients in Ethiopia. Adamu H; Petros B; Zhang G; Kassa H; Amer S; Ye J; Feng Y; Xiao L PLoS Negl Trop Dis; 2014 Apr; 8(4):e2831. PubMed ID: 24743521 [TBL] [Abstract][Full Text] [Related]
17. [The significance of cryptosporidiosis for the health of calves in Switzerland]. Olias P; Dettwiler I; Hemphill A; Deplazes P; Steiner A; Meylan M Schweiz Arch Tierheilkd; 2018 Jun; 160(6):363-374. PubMed ID: 29905160 [TBL] [Abstract][Full Text] [Related]